Benitec Biopharma Inc.(BNTC)
Biotechnology
Gene Therapy & Gene Editing
Recent Insider Trades
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2025-12-29 | SUVRETTA CAPITAL MANAGEMENT, LLC Director, 10% Owner | Purchase | +144,223 | -80.70%1,848,156 | $13.20 | $1,903,133 | View SEC filing | |
| 2025-12-22 | SUVRETTA CAPITAL MANAGEMENT, LLC Director, 10% Owner | Purchase | +46,141 | -80.85%1,826,653 | $11.68 | $538,972 | View SEC filing | |
| 2025-11-10 | SUVRETTA CAPITAL MANAGEMENT, LLC Director, 10% Owner | Purchase | +1,481,481 | -79.34%1,819,812 | $13.50 | $19,999,994 | View SEC filing | |
| 2025-04-02 | SUVRETTA CAPITAL MANAGEMENT, LLC Director, 10% Owner | Purchase | +16,497 | -87.85%1,068,701 | $12.83 | $211,736 | View SEC filing | |
| 2025-03-28 | SUVRETTA CAPITAL MANAGEMENT, LLC Director, 10% Owner | Purchase | +900,000 | -86.66%1,066,764 | $13.00 | $11,700,000 | View SEC filing | |
| 2024-12-26 | SUVRETTA CAPITAL MANAGEMENT, LLC Director, 10% Owner | Purchase | +47,520 | -87.93%960,554 | $11.09 | $527,174 | View SEC filing | |
| 2024-12-05 | SUVRETTA CAPITAL MANAGEMENT, LLC Director, 10% Owner | Purchase | +42,000 | -87.94%955,124 | $9.60 | $403,200 | View SEC filing | |
| 2024-11-21 | SUVRETTA CAPITAL MANAGEMENT, LLC Director, 10% Owner | Purchase | +41,436 | -87.95%950,314 | $10.05 | $416,616 | View SEC filing | |
| 2023-08-14 | BUCHI J KEVIN Director | Purchase | +103,626 | +36488.03%103,910 | N/A | N/A | View SEC filing | |
| 2023-08-14 | Boston Megan Executive Director | Purchase | +51,814 | +100.00%51,814 | N/A | N/A | View SEC filing | |
| 2021-12-09 | Oliveira Steven Michael 10% Owner | Purchase | +331,877 | +49.67%1,000,000 | $4.51 | $1,497,454 | View SEC filing |
1-11 of 11
Page 1 of 1